Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Athena Technology Acquisition (ATEK) Competitors

Athena Technology Acquisition logo

ATEK vs. CRTX, OMCL, HSTM, MDRX, RRAC, PORT, ENPC, AXAC, EVE, and DHHC

Should you be buying Athena Technology Acquisition stock or one of its competitors? The main competitors of Athena Technology Acquisition include Cortexyme (CRTX), Omnicell (OMCL), HealthStream (HSTM), Veradigm (MDRX), Rigel Resource Acquisition (RRAC), Southport Acquisition (PORT), Executive Network Partnering (ENPC), AXIOS Sustainable Growth Acquisition (AXAC), EVe Mobility Acquisition (EVE), and DiamondHead (DHHC).

Athena Technology Acquisition vs. Its Competitors

Cortexyme (NASDAQ:CRTX) and Athena Technology Acquisition (NYSE:ATEK) are both small-cap health care technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, media sentiment, institutional ownership and valuation.

Cortexyme has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500. Comparatively, Athena Technology Acquisition has a beta of 0.37, meaning that its stock price is 63% less volatile than the S&P 500.

63.2% of Cortexyme shares are owned by institutional investors. Comparatively, 17.3% of Athena Technology Acquisition shares are owned by institutional investors. 27.9% of Cortexyme shares are owned by company insiders. Comparatively, 88.4% of Athena Technology Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Cortexyme had 1 more articles in the media than Athena Technology Acquisition. MarketBeat recorded 1 mentions for Cortexyme and 0 mentions for Athena Technology Acquisition. Cortexyme's average media sentiment score of 0.59 beat Athena Technology Acquisition's score of 0.34 indicating that Cortexyme is being referred to more favorably in the media.

Company Overall Sentiment
Cortexyme Positive
Athena Technology Acquisition Neutral

Athena Technology Acquisition's return on equity of 0.00% beat Cortexyme's return on equity.

Company Net Margins Return on Equity Return on Assets
CortexymeN/A -70.96% -63.53%
Athena Technology Acquisition N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CortexymeN/AN/A-$89.94M-$2.97-0.54
Athena Technology AcquisitionN/AN/AN/AN/AN/A

Summary

Cortexyme beats Athena Technology Acquisition on 4 of the 7 factors compared between the two stocks.

Get Athena Technology Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATEK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATEK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATEK vs. The Competition

MetricAthena Technology AcquisitionHolding Offices Industry SectorNYSE Exchange
Market Cap$101.50M$225.31M$2.09B$20.94B
Dividend YieldN/A3.17%13.77%3.58%
P/E RatioN/A0.1712.2829.13
Price / SalesN/A504.162,835,064.8553.05
Price / CashN/A123.7057.5123.54
Price / BookN/A8.103.075.45
Net IncomeN/A-$11.59M-$456.46M$992.10M

Athena Technology Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATEK
Athena Technology Acquisition
N/A$10.00
flat
N/AN/A$101.50MN/A0.002,021
CRTX
Cortexyme
N/A$1.61
-1.2%
N/A+154.7%$48.54MN/A-0.5455
OMCL
Omnicell
3.0519 of 5 stars
$33.62
+5.4%
$46.71
+38.9%
-26.7%$1.46B$1.11B67.243,670Positive News
HSTM
HealthStream
4.5644 of 5 stars
$27.74
+3.0%
$31.00
+11.8%
-4.4%$798.24M$291.65M41.401,093Positive News
MDRX
Veradigm
2.8141 of 5 stars
$4.85
flat
$13.00
+168.0%
-48.9%$525.09M$1.53B0.008,000News Coverage
RRAC
Rigel Resource Acquisition
N/A$11.50
flat
N/AN/A$368.81MN/A0.002,021
PORT
Southport Acquisition
N/A$40.00
+73.9%
N/AN/A$231.52MN/A0.002,021Gap Up
High Trading Volume
ENPC
Executive Network Partnering
N/A$5.45
+2.3%
N/A-17.2%$228.98MN/A0.001High Trading Volume
AXAC
AXIOS Sustainable Growth Acquisition
N/A$10.43
flat
N/AN/A$228.66MN/A0.00N/AHigh Trading Volume
EVE
EVe Mobility Acquisition
N/A$11.27
flat
$5.00
-55.6%
N/A$175.77MN/A0.004
DHHC
DiamondHead
N/A$4.06
+1.2%
N/A-33.1%$175.11MN/A0.002Positive News

Related Companies and Tools


This page (NYSE:ATEK) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners